Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_63_библиотеки_им_акад_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
12.10.2026
Размер:
4 Мб
Скачать
☆
Chapter 4 Local anaesthetics and analgesics
58
drugs that are classed as analgesic mixtures. For
example, co-codamol tablets contain paracetamol
and codeine phosphate in varying ratios (available
preparations are codeine 8mg/paracetamol 500mg,
codeine 15mg/paracetamol 500mg and codeine
30mg/paracetamol 500mg). Another analgesic
mixture that you will come across regularly is
co-dydramol, which contains dihydrocodeine 10mg
and paracetamol 500mg per tablet.
Tramadol
Tramadol is a strong analgesic painkiller but a
moderate strength opioid. It can be used in acute
and chronic pain. Like other opioids, it has the
potential to become addictive and patients should
be monitored for signs of this as well as tolerance
(the need for more of the drug to produce the same
response), and the lowest possible does to produce
the analgesic effect should be administered. Daily
does of over 400mg should not be given. Although
able to be used in chronic pain, the manufacturer
recommends that tramadol should not be adminis-
tered for longer than absolutely necessary. Dose
adjustments (reductions) may be needed in the
over-75s and its use is not recommended in chil-
dren under 12.
When a patient starts taking any opioid, it is very
important that you warn them of the possible sed-
ative effects and discuss the dangers of driving or
operating heavy machinery. This is a requirement
of legislation amending the Road Traffic Act to
incorporate The Drug Driving (Specified Limits)
(England & Wales) (Amendment) Regulations 2015.
Opioid antagonists
As discussed above, respiratory depression is a
side-effect of opiates. Therefore, in opioid over-
dose, an antidote is necessary. This comes in the
form of a drug called naloxone, which attracts
strongly to all three opioid receptors. Naloxone
blocks the actions of morphine and our own endor-
phins by occupying the opioid receptors without
bringing about any response, so effectively stop-
ping anything else connecting to the receptor.
Naloxone therefore quickly reverses the effects of
opioid drugs.
Drugs for neuropathic pain
Neuropathic pain is caused by damage to nerves
and often does not respond to the common pain-
killers we have discussed so far. Newer drugs, or
drugs used for other purposes have been found to
be beneficial in managing this type of pain in some
patients. Very often these drugs are prescribed to
patients with long-term intractable pain who may
be under the management of a specialist pain team
or in a shared care arrangement between the pain
team and their GP.
Amitriptyline
Amitriptyline is a tricyclic antidepressant drug that
has been used for many years. As other antidepres-
sants were developed this drug, due to its many
side-effects, became less favoured in the treatment
of depression (see Chapter 12 for its mechanism of
action), although evidence is emerging of its use-
fulness in treating pain that has a neuropathic com-
ponent. The BNF section on managing neuropathic
pain suggests its use, or its close relative nortrip-
tyline, or the use of anti-epileptic medicines. The
use of amitriptyline in this condition is unlicensed
but there is a growing body of evidence to sup-
port its use as seen in a Cochrane review of 2015
(Moore et al. 2015).
Gabapentin and pregabalin
These two drugs are anti-epileptic medications
and are sometimes referred to as gabapentinoids.
Clinical tip
The main clinical use of naloxone is
to treat respiratory depression caused by
opioid drugs in overdose, whether acciden-
tal or intentional. It is usually given intra-
venously, and its effects are immediate.
It has a relatively short half-life, as it is
quickly metabolized by the liver. Therefore,
when treating a patient, you may see the
drug repeatedly used in order to maintain
respiratory function.
https://t.me/medicina_free
Chapter 4 Local anaesthetics and analgesics
59
The pharmacodynamic mechanism is to block
calcium channel mediated neurotransmission but
the actual link to the analgesic effect is poorly
understood and may be related to activity in the
dorsal horn of the spinothalamic tract (Chinchol-
kar 2018). These drugs have been licensed for
treatment of peripheral neuropathic pain and their
use has increased dramatically over recent years
(Morrison et al. 2017). They are of proven benefit
to some patients – many patients and prescribers
find the side-effects and risk of adverse reactions
to outweigh the potential benefits. There is a risk
of addiction and concomitant misuse with opioid
medication and as such they became controlled
drugs, subject to the Misuse of Drugs Act 1971 in
2019.
Case studies
1
Dawn Mason, a 40-year-old woman, has undergone major abdominal surgery. The medi-
cal staff have decided to change her analgesia from opioids to NSAID medication as she is
4 days post-surgery. A health care assistant approaches you and asks you to explain the mode
of action of the different types of analgesia and why the patient is now stepping down from one
set of analgesia to another. Discuss this with reference to:
■ the mode of action of these two drugs;
■ the importance of stepping down post-operative analgesia;
■ the maintenance required to achieve a steady plasma concentration of analgesic;
■ how you would put this information into terms that the health care assistant will understand.
2
Alex Smith is a 9-year-old boy who has sustained a broken arm after falling from his bike. The
doctor has prescribed him paracetamol and ibuprofen. The dose he can have for each drug is:
■ ibuprofen 200mg every 6–8 hours;
■ paracetamol 500mg every 4–6 hours, maximum 2g in 24 hours.
You must explain to Alex and his parents how these drugs work and the importance of regular
medication to manage Alex’s pain. Discuss this with reference to:
■ pharmacodynamics: mode of action of the two drugs;
■ pharmacokinetics: the need for regular dosing to achieve a therapeutic plasma concentration;
■ how you would put this information in terms that Alex and his parents will understand.
3
Michael Nozic is a 56-year-old male who has a history of osteoarthritis, worsened by hip dys-
plasia. His pain has become much less tolerable during the past year and his ability to carry
out certain activities of living has been reduced drastically. He was admitted for a total hip re-
placement and has just returned from theatre to your ward. He has had a spinal anaesthetic and
sedation during the procedure.
With reference to his spinal anaesthetic, what nursing observations would you make on Mr
Nozic during his immediate post-operative care?
4
Ruby Mtumba is a 71-year-old female. She has been referred to the pain team because her
pain is becoming more persistent and widespread. She is complaining of pain in her lower back,
neck and shoulders. This lady is a widow, but her daughter has moved in to help her, especially
as the pain is stopping her carry out daily activities.
→
https://t.me/medicina_free
Chapter 4 Local anaesthetics and analgesics
60
With reference to the WHO’s analgesic ladder (see Figure 4.8), explain how this lady’s pain
should have been pharmacologically managed.
5
Jonti Williams is aged 35 and has neuropathic pain resulting from a slipped disc causing sciatica.
Jonti has Down’s Syndrome and suffers from focal epileptic seizures. His current anti-epileptic
medication is gabapentin 300mg three times daily.
Using the BNF, look at the range of medication that may be prescribed for Jonti’s pain, and any
potential interactions with his current medication.
→
Key learning points
Introduction
▶
Pain alerts us to tissue damage.
▶
Pain is a defence mechanism.
▶
We can suffer pain without tissue damage.
▶
Pain is a difficult concept to define.
▶
At rest, the inside of a neurone carries a negative charge.
▶
For the neurone to fire, the inside must become positive.
▶
Sodium moves into the neurone to allow it to become positively charged.
▶
The pre-synaptic neurone allows calcium to enter.
▶
The neurotransmitter allows the post-synaptic neurone to be excited or inhibited.
▶
Pain is received by nociceptors.
▶
Nociceptors are fired by heat, pressure or chemicals.
▶
Nociceptors are non-adapting, high-threshold fibres.
▶
Pain is transmitted by A-delta and C fibres.
▶
A-delta and C fibres synapse in the dorsal horn of the spinal cord.
▶
The pain impulse is interpreted in several areas in the brain.
▶
The analgesic system is a descending one.
▶
It is thought to close the gate to pain stimuli.
▶
Endorphins, dynorphins and enkephalins are important in modifying pain.
▶
Nociceptive pain results from tissue damage.
▶
Neuropathic pain is damage to nerves in the peripheral or central nervous system.
▶
The duration of pain results in it being classified as either acute or chronic.
Local anaesthetics
▶
Produce a reversible loss of sensation.
▶
There are two classes: esters and amides.
▶
Block sodium channels in the neurone.
▶
Usually used as dilute preparations (e.g. lidocaine 1%).
→
https://t.me/medicina_free
Chapter 4 Local anaesthetics and analgesics
61
▶
Can cause vasodilation (so are often given with adrenaline).
▶
Can be given topically, via infiltration, as a nerve block, as an epidural, as a spinal anaesthet-
ic or as an intravenous injection.
▶
Can cause central nervous and cardiovascular side-effects.
Non-steroidal anti-inflammatory drugs
▶
Used for mild-to-moderate pain.
▶
Lower body temperature and have anti-inflammatory properties.
▶
Block the production of prostaglandins.
▶
Block cyclooxygenase pathways.
▶
Limit prostaglandin effects on the nociceptors.
▶
Have marked gastrointestinal and renal side-effects.
▶
Paracetamol damages the liver if the recommended dose is not followed.
▶
Paracetamol overdose is treated with N-acetylcysteine.
Opioid analgesics
▶
Given for moderate-to-severe pain.
▶
Work on receptors in the central nervous system.
▶
Some drugs are natural compounds, while some are synthetic agents.
▶
Block entry of calcium into pre-synaptic neurone.
▶
Open potassium channels making it harder for the pain neurone to fire.
▶
Main effects are on the central nervous system and gastrointestinal tract.
▶
Morphine is the gold standard by which other opioids are measured.
▶
Morphine can cause tolerance and dependence.
▶
Fentanyl is a powerful synthetic opiate analgesic similar to, but approximately 100 times more
potent than, morphine.
▶
Fentanyl is used to treat patients with severe pain, or to manage pain after surgery.
▶
Fentanyl is also used to treat people with chronic pain who are physically tolerant to opiates.
▶
Codeine is a weak opioid.
▶
Tramadol is an opioid of moderate strength.
▶
Naloxone is given to reverse the effects of morphine.
Drugs for neuropathic pain
▶
Amitriptyline is a tricyclic antidepressant useful in managing neuropathic pain.
▶
Gabapentin and pregabalin are anti-epileptic drugs useful in managing neuropathic pain.
They are controlled drugs.
→
https://t.me/medicina_free
Chapter 4 Local anaesthetics and analgesics
62
Calculations
1 Pethidine 100mg in 2mL is available to you. However, the patient has been prescribed
75mg. How much do you give?
2 A patient requires 1000mg of paracetamol in liquid form. The stock you have contains 125mg
in 5mL. How many mL would you give?
3 Codeine is available in three strengths as tablets: 5mg, 10mg and 20mg. What is the least
number of tablets you can give if the prescription is a dose of 50mg?
4 900mg of gabapentin is required to be given. You have 0.3g capsules. How many would you
give?
5 A patient is prescribed an injection of 80mg of pethidine. You have available 100mg in 1mL.
How much fluid would you draw up?
6 You have oral amitriptyline 10mg in a 5mL solution. The patient is prescribed 25mg. How
much do you administer?
7 The maximum dose of paracetamol is 4g in a 24-hour period. The tablets are 500mg. What
is the maximum number of tablets you can give in a 24-hour period?
8 A patient requires 4mg of intramuscular morphine sulphate. You have reconstituted the mor-
phine to make a dose of 10mg in 1mL. How much do you draw up?
9 35mg of codeine is to be given to a patient subcutaneously. You have available 50mg in
1mL. How much do you administer?
10 Fentanyl 75mcg is to be given intravenously. You have fentanyl 0.1mg in 1mL available. How
much would you draw up
Multiple-choice questions
Try answering these multiple-choice questions to test what you have learned from reading this
chapter. You can check your answers at the end of this book.
1. What is the role of prostaglandins in the reception of pain?
a) They make the nociceptors more sensitive
b) They directly stimulate the nociceptors
c) They stimulate the release of bradykinin
d) They only act on receptors in the central nervous system
2. Local anaesthetic agents work by …
a) Opening potassium channels
b) Opening sodium channels
→
https://t.me/medicina_free
Chapter 4 Local anaesthetics and analgesics
63
c) Blocking potassium channels
d) Blocking sodium channels
3. Why are some local anaesthetics given with adrenaline?
a) Adrenaline is needed in order for local anaesthetics to work
b) Adrenaline counteracts the vasodilation caused by local anaesthetics
c) Adrenaline makes local anaesthetics work more quickly
d) Adrenaline helps the local anaesthetic enter the cells
4. NSAIDs work by …
a) Blocking production of bradykinin
b) Making the neurone fire more frequently
c) Stimulating the body’s own analgesic system
d) Blocking production of prostaglandins
5. Why is it important to tell a patient who has been prescribed paracetamol to be
careful when buying OTC medicines?
a) It could be expensive for them
b) You must only take paracetamol on its own
c) Paracetamol is often combined with cold and flu remedies
d) Paracetamol easily interacts with OTCs
6. Ibuprofen must be taken with caution if the patient is also taking lithium – why?
a) The patient may forget to take the medicine
b) It may increase the lithium level in the blood
c) It will make the lithium inactive
d) Ibuprofen also affects mood
7. One of the mechanisms of opiates is thought to be …
a) Blockage of calcium channels
b) Opening of calcium channels
c) Blockage of sodium channels
d) Opening of sodium channels
8. Which of the following channels are blocked by gabapentin?
a) Sodium
b) Potassium
c) Calcium
d) Chloride
→
→
https://t.me/medicina_free
Chapter 4 Local anaesthetics and analgesics
64
Recommended further reading
Barber, P. (ed.) (2013) Medicine Management for Nurses
Case Book. Maidenhead: Open University Press.
Brenner, G.M. and Stevens, C.W. (2017) Pharmacology,
5th edition. Philadelphia, PA: Elsevier.
Chincholkar, M. (2018) Analgesic mechanisms of gab-
apentinoids and effects in experimental pain models:
a narrative review, British Journal of Anaesthesia,
120 (6): 1315–34.
Cornock, M. (2005) Pain relief and the law, Nursing
Standard, 19 (51): 28.
Downie, G., Mackenzie, J. and Williams, A. (2007) Phar-
macology and Medicines Management for Nurses,
4th edition. Edinburgh: Churchill Livingstone.
Gatford, J.D. and Phillips, N. (2011) Nursing Calculations,
8th edition. Edinburgh: Churchill Livingstone Elsevier.
Godfrey, H. (2005) Physiology of pain: understanding
pain, Part 1: physiology of pain, British Journal of
Nursing, 14 (16): 846–52.
Godfrey, H. (2005) Pain management: understanding
pain, Part 2: pain management, British Journal of
Nursing, 14 (17): 904–9.
Greenstein, B. and Gould, D. (2008) Trounce’s Clinical
Pharmacology for Nurses, 18th edition. New York:
Churchill Livingstone.
Hamad, A.M., Sutcliffe, A.M. and Knox, A.J. (2004) Aspi-
rin induced asthma: clinical aspects, pathogenesis and
management, Drugs, 64 (21): 2417–32.
Karch, A.M. (2017) Focus on Nursing Pharmacology, 7th
edition. Philadelphia, PA: Lippincott Williams & Wilkins.
Lapham, R. (2015) Drug Calculations for Nurses: A
Step-by-Step Approach, 4th edition. London: Arnold.
Mann, E. and Redwood, S. (2000) Improving pain man-
agement: breaking down the invisible barrier, Brit-
ish Journal of Nursing, 9 (19): 2067–72.
Melzack, R. and Wall, P.D. (1965) Pain mechanisms: a
new theory, Science, 150: 971–9.
Moore, R.A., Derry, S., Aldington, D., Cole, P. and Wiffen,
P.J. (2015) Amitriptyline for neuropathic pain in adults,
Cochrane Database of Systematic Reviews, Issue 7. Art.
CD008242 (DOI: 10.1002/14651858.CD008242.pub3).
Morrison, E.E., Sandilands, E.A. and Webb, D.J. (2017)
Gabapentin and pregabalin: do the benefits outweigh
thee harms?, Journal of the Royal College of Physi-
cians Edinburgh, 47 (4): 310–13.
National Institute for Health and Care Excellence (NICE)
(2007) Clinical Guideline CG52: Drug Misuse in
Over 16s – Opioid Detoxification. London: NICE.
Nursing and Midwifery Council (NMC) (2018) Standards
of Proficiency for Registered Nurses. London: NMC.
Royal College of Emergency Medicine (RCEM) (2017)
Intravenous Regional Anaesthesia for Distal Fore-
arm Fracture (Bier’s Block). London: RCEM.
Scottish Intercollegiate Guidelines Network (SIGN)
(2013) SIGN 136: Management of Chronic Pain. A
National Clinical Guideline. Edinburgh: SIGN.
Simonson, T., Aarbakke, J., Kay, I., Coleman, I., Sinnott,
P. and Lyssa, R. (2006) Illustrated Pharmacology for
Nurses. London: Hodder Arnold.
Sneader, W. (2000) The discovery of aspirin: a reappraisal,
British Medical Journal, 321 (7276): 1591–4.
UK Government (1971) The Misuse of Drugs Act.
UK Government (2015) The Drug Driving (Specified
Limits) (England & Wales) (Amendment) Regula-
tions. Retrieved from: https://www.legislation.gov.
uk/ukdsi/2015/9780111128824.
Wong, D.L. and Baker, C.M. (2001) Smiling faces as an
anchor for pain intensity scales, Pain, 89 (2/3): 295–300.
World Health Organization (WHO) (1966) Cancer Pain
Relief. Geneva: WHO.
9. Why is it good practice to ensure patients are prescribed an aperient when taking
morphine?
a) Because morphine makes some people vomit
b) The patient will be having a poor diet
c) The patient is not likely to be moving
d) It reduces the rate at which the gastrointestinal system moves
10. What drug is given to reverse the effects of morphine?
a) Neomycin
b) Nandrolone
c) Naloxone
d) Neostigmine
→
https://t.me/medicina_free
65
Chapter contents
Learning objectives
Introduction
Bacterial infection
Antibiotic actions
Interference with folate
Trimethoprim
Beta-lactam antibiotics
Penicillins
Cephalosporins
Clavulanic acid
Interference with protein synthesis
Tetracyclines
Chloramphenicol
Aminoglycosides
Macrolides
Lincosamides
Inhibition of bacterial DNA
Fluoroquinolones
Antibiotic resistance and antimicrobial
stewardship
Causes of antibiotic resistance
Drugs used to treat tuberculosis
Isoniazid
Rifampicin
Pyrazinamide
Viral infections
Viral mechanisms
Human immunodeficiency virus
Antiretroviral therapy
Nucleoside reverse transcriptase inhibitors
Non-nucleoside reverse transcriptase inhibitors
Protease inhibitors
Other antiviral drugs in HIV treatment and
prophylaxis
PrEP and PEP
Other viral infections and antiviral drug
treatments
Aciclovir
Ganciclovir
Immunoglobulins
Interferons
Fungal infections
Moulds
True yeasts
Yeast-like fungi
Antifungal drugs
Amphotericin
Clotrimazole
Nystatin
Griseofulvin
Azoles
Ketoconazole
Fluconazole
Miconazole
Flucytosine
Terbinafine
Protozoa
Apicomplexa and malaria
Quinine
Other drugs
Flagellates
Metronidazole
Amoeboflagellates
Tinidazole
Case studies
Key learning points
Calculations
Multiple choice questions
Recommended further reading
Antimicrobials
5
https://t.me/medicina_free
Chapter 5 Antimicrobials
66
Introduction
Part of the nurse’s role is to ensure that medicines
are administered appropriately. The Nursing and
Midwifery Council’s Standards for Pre-Registration
Nursing programmes published in May 2018 state
that education must
ensure that field-specific content in relation to
the law, safeguarding, consent, pharmacology
and medicines administration and optimisa-
tion is included for entry to the register in one
or more fields of nursing practice
This is backed up by the Standards of Proficiency
for Registered Nurses as follows:
Platform 2: Promoting health and preventing ill
health
2.12 protect health through understanding and
applying the principles of infection prevention
and control, including communicable disease
surveillance and antimicrobial stewardship
and resistance
The Global Burden of Disease Study of 2017 shows
that communicable (or infectious) disease is still
a major cause of death and disability through-
out the world. Many micro-organisms live either
inside or on the outside of the human body. These
can live harmlessly on the host or can cause dis-
ease. Other micro-organisms are present in the
external environment and are introduced into our
bodies when eating and drinking, breathing or on
physical contact.
Micro-organisms that live in or on our bodies
for the most part have a harmless relationship with
us and can be beneficial – for example, bacteria in
the GI system break down foodstuffs, allowing us to
absorb nutrients. Unfortunately, at times of vulnera-
bility these same organisms can cause infection and
damage. Other micro-organisms that are not nor-
mally present in the body attempt to invade our tis-
sues, causing damage that can be life-threatening.
Any invasion or abnormal growth pattern of
micro-organisms which causes our body to defend
itself is called an infection. A common example
would be respiratory infections – the inflammation
of the membrane that lines the respiratory tract
and associated structures.
Micro-organisms are categorized into four main
groups: bacteria, viruses, protozoa and fungi. Other
groups such as algae and parasitic infections will
not be considered here. Bacteria and fungi are capa-
ble of existing independently of their host, i.e. us.
Some protozoa and certainly viruses need the mech-
anisms from our cells in order to replicate and grow.
Learning objectives
After studying this chapter, you should be able to:
■ Describe a bacterial cell.
■ Explain the mode of action of a range of antibiotics used in practice settings.
■ Demonstrate an understanding of what unwanted effects antibiotics have on humans.
■ Discuss drugs that are used to treat tuberculosis.
■ Define what is meant by viral disease.
■ Describe the mode of action and side-effects of antiviral medicines.
■ Identify the three main causes of fungal infection.
■ Explain how antifungal medicines act.
■ Demonstrate an understanding of the links between the pharmacology of antimicrobial ther-
apies and the care given by the health practitioner.
■ Solve correctly a number of drug calculations with regard to antimicrobial medicines.
https://t.me/medicina_free
Chapter 5 Antimicrobials
67
This chapter is designed to provide an introduc-
tion to some of the medicines used in combating
infections caused by micro-organisms. These drugs
are referred to as antimicrobials. The chapter
covers antibiotic therapy, antiviral therapy, anti-
protozoa therapy and, finally, antifungal therapy.
We provide examples of common drugs that you
are likely to encounter in your clinical practice.
Bacterial infection
Bacteria are classified into several types based on
their shape. When viewed through a microscope,
some look like rods and are called bacilli. Some
have a curved rod shape and are known as vibrio.
Others are round and are called cocci. Still others
have a spiral or corkscrew shape and are known
as spirilla or spirochetes. Bacteria are also catego-
rized by whether they take up a stain called gram
stain: bacteria that absorb this stain are termed
gram positive, while those that do not are gram
negative.
Whether or not a gram stain is taken up depends
on the thickness of the cell walls of the bacte-
ria. Gram-negative bacteria have a thin cell wall,
whereas the cell wall of gram-positive organisms
is much thicker and can absorb the stain.
Bacteria cells are different from those of
humans. Bacteria do not have a nucleus and so
are called prokaryotes. Animal (including human)
cells do have a nucleus and are called eukary-
otes. This and other differences between bacteria
and human cells is important, as antibiotics are
designed to target these differences, thus combat-
ting the bacteria while leaving our own cells with
little or no damage.
On the very outside of a bacterium is a wall
made largely from a sugar called peptidoglycan.
This is unique to prokaryotic cells. Beneath this
wall is a plasma membrane very similar to our
own that consists of a sandwich of phospholipids
and proteins. Together, the cell wall and plasma
membrane are called the bacterial envelope.
A bacterium contains cytoplasm which car-
ries similar organelles to our own. However, the
genetic material is arranged in one long strand
that floats around in the cytoplasm. A prokaryotic
cell does not have any mitochondria and energy
production is carried out in the plasma membrane
(see Figure 5.1).
Antibiotics are described as being bactericidal
(i.e. they kill bacteria) or bacteriostatic (i.e. they
prevent the growth and replication of the bacteria
so they do not multiply and they die after their nat-
ural cycle has elapsed). This gives the body’s nat-
ural defence mechanisms time to recognize and
deal with the infection. The distinction between
these two terms is not black and white because
in certain conditions a bactericidal antibiotic may
only have a bacteriostatic effect and vice versa.
Their spectrum of effects can be governed by
dosage, outside influences and the health of the
patient.
Selective toxicity is the ability of the antimi-
crobial to harm a pathogen (bacteria) without
harming our own cells. Therefore, when discuss-
ing selective toxicity in terms of an antibiotic,
health care practitioners are referring to the range
between the dose necessary to inhibit or destroy
the bacteria and the dose at which our own cells
become harmed. Thus, an antibiotic that is far
more toxic to the bacteria than our cells is said to
have a greater selective toxicity.
ANTIBIOTIC ACTIONS
Different antibiotics interfere with bacterial cell
processes in different ways and we will explore
each in turn.
Interference with folate
Folate is a vitamin required by both bacterial and
human cells. Bacteria must make their own folate
and cannot absorb it directly from the environ-
ment. Humans cannot make their own and must
obtain it from their diet or through a supplement
if needed.
A group of antibiotics called sulfonamides
exploit this unique ability of bacterial cells. Bac-
teria need a substance called para-aminobenzoic
acid (PABA) as a precursor to synthesize the folate
they need. Sulfonamides are structural analogues
of PABA and act as a competitive antagonist and
are taken up by the bacteria as a pseudo-precursor
preventing the synthesis of folate. In this way,
https://t.me/medicina_free